# JUBLPHARMA — Jubilant Pharmova Limited

> Jubilant Pharmova Limited (JUBLPHARMA) on the NSE: 5,683 sessions of split-adjusted history from 2003.

Canonical: https://patternsradar.com/s/JUBLPHARMA

## Latest session

- Close: 880.35 INR (1.07% on the day), 2026-08-21
- Delivery: 54.98% of volume taken to demat (20-day average 55.35%)
- Volume: 2.29L shares, turnover ₹20.2Cr
- Relative volume: 0.83× of its own 20-day average

## Technicals

- RSI(14): 35.74
- ATR(14): 31.26
- SMA 50: 956.5, SMA 200: 974.39
- 52-week range: 786.05 – 1,184.8 (-25.7% from the high)

## Performance

- 1 week 1.68%, 1 month -9.32%, 3 months -12.52%
- 6 months -1.58%, 1 year -18.3%

## Fundamentals

- Market cap: 14,022.3 crore
- P/E (TTM): 39.9 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 22.06 INR, split-adjusted to match the price series
- Revenue growth: 17.29% YoY, -2.65% QoQ
- Profit growth: -44.98% YoY, -52.72% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 27.87% | -23.73% |
| 3y | 10.29% | — |
| 5y | 3.18% | -17.29% |
| 6y | -0.49% | -12.84% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 1,752.3 | 1,615.3 | 144.5 | 102.5 | 6.47 | 5.85% |
| 2024-12-31 | 1,821.7 | 1,681.2 | 130.8 | 100.7 | 6.37 | 5.53% |
| 2025-03-31 | 1,928.8 | 1,731.3 | 206.1 | 151.3 | 9.71 | 7.84% |
| 2025-06-30 | 1,900.7 | 1,758.2 | 154.5 | 102.5 | 6.49 | 5.39% |
| 2025-09-30 | 1,966.4 | 1,780 | 190.4 | 119.9 | 7.59 | 6.1% |
| 2025-12-31 | 2,122.5 | 2,009.8 | 93.5 | 55.8 | 3.52 | 2.63% |
| 2026-03-31 | 2,290 | 2,124 | 176 | 119.3 | 7.55 | 5.21% |
| 2026-06-30 | 2,229.4 | 2,162.9 | 86.4 | 56.4 | 3.57 | 2.53% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 47.68%
- Public: 51.77%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-10: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_184751_10082026192929_iXBRL_WEB.html
- 2026-07-24: dividend
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697849_21072026121854_WEB.xml
- 2026-05-22: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160344_22052026200549_iXBRL_WEB.html
- 2026-04-18: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1654334_18042026062307_WEB.xml
- 2026-02-06: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_140729_06022026134904_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1607419_21012026060143_WEB.xml
- 2025-10-31: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_123971_31102025191537_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 117 events are indexed for this instrument.

## About the instrument

- Listed: 2003-09-30 — latest session 2026-08-21 (5,683 sessions)
- ISIN: INE700A01033
- Series: EQ
- Liquidity rank: #690 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/JUBLPHARMA.